A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Working paper
Ahern DJ. et al, (2021)
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
Journal article
Slevin SM. et al, (2020), Journal of Crohn's and Colitis, 14, 1446 - 1461
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Journal article
Ogbe A. et al, (2020)
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions
Journal article
Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5
Systems-level analysis of monocyte responses in inflammatory bowel disease identifies IL-10 and IL-1 cytokine networks that regulate IL-23
Journal article
Aschenbrenner D. et al, (2019)
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
Journal article
Schulthess J. et al, (2019), Immunity, 50, 432 - 445.e7
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells
Journal article
Kurioka A. et al, (2018), Frontiers in Immunology, 9
Host-microbial crosstalk in the pathogenesis of colon cancer in Primary sclerosing cholangitis
Conference paper
Neyazi M. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S97 - S97
Innate Lymphoid Cells in Intestinal Inflammation
Journal article
Geremia A. and Arancibia-Cárcamo CV., (2017), Frontiers in Immunology, 8
Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease
Journal article
Gwela A. et al, (2017), Journal of Crohn's and Colitis, 11, 1124 - 1134
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
Journal article
West NR. et al, (2017), Nature Medicine, 23, 579 - 589
RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease
Journal article
de Wit J. et al, (2016), Journal of Allergy and Clinical Immunology, 137, 960 - 963
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
Journal article
Paterson AM. et al, (2015), Journal of Experimental Medicine, 212, 1603 - 1621
SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS
Journal article
De Wit J. et al, (2014), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32, 811 - 811
Expression and regulation of the TGF-beta-activating integrin alpha(v)beta(8) on human dendritic cells
Conference paper
Fenton TM. et al, (2013), IMMUNOLOGY, 140, 147 - 148
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
Journal article
Geremia A. et al, (2011), Journal of Experimental Medicine, 208, 1127 - 1133
Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice
Journal article
Keszei M. et al, (2011), International Immunology, 23, 149 - 158
Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis
Journal article
Izcue A. et al, (2008), Immunity, 28, 559 - 570
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism
Journal article
Coombes JL. et al, (2007), Journal of Experimental Medicine, 204, 1757 - 1764